{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:48:54Z","timestamp":1792032534746,"version":"4.4.0"},"reference-count":293,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>In 2021, the World Health Organization classified isocitrate dehydrogenase (IDH) mutant gliomas as a distinct subgroup of tumors with genetic changes sufficient to enable a complete diagnosis. Patients with an IDH mutant glioma have improved survival which has been further enhanced by the advent of targeted therapies. IDH enzymes contribute to cellular metabolism, and mutations to specific catalytic residues result in the neomorphic production of D-2-hydroxyglutarate (D-2-HG). The accumulation of D-2-HG results in epigenetic alterations, oncogenesis and impacts the tumor microenvironment via immunological modulations. Here, we summarize the molecular, cellular, and clinical implications of IDH mutations in gliomas as well as current diagnostic techniques.<\/jats:p>","DOI":"10.3390\/biology13110885","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T13:09:27Z","timestamp":1730466567000},"page":"885","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications"],"prefix":"10.3390","volume":"13","author":[{"given":"Kristian A.","family":"Choate","sequence":"first","affiliation":[{"name":"Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan P. S.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA"},{"name":"Department of Chemistry, Northern Michigan University, Marquette, MI 49855, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Jennings","sequence":"additional","affiliation":[{"name":"Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA"},{"name":"School of Clinical Sciences, Northern Michigan University, Marquette, MI 49855, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Winn","sequence":"additional","affiliation":[{"name":"Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA"},{"name":"Department of Biology, Northern Michigan University, Marquette, MI 49855, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Mann","sequence":"additional","affiliation":[{"name":"Upper Michigan Brain Tumor Center, Northern Michigan University, Marquette, MI 49855, USA"},{"name":"School of Clinical Sciences, Northern Michigan University, Marquette, MI 49855, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-018-03015-9","article-title":"Prevalence of Symptoms in Glioma Patients Throughout the Disease Trajectory: A Systematic Review","volume":"140","author":"Margriet","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","article-title":"Glioma","volume":"1","author":"Michael","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 Who Classification of Tumors of the Central Nervous System: A Summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA Methylation-Based Classification of Central Nervous System Tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/humu.21365","article-title":"Cold PCR HRM: A Highly Sensitive Detection Method for IDH1 Mutations","volume":"31","author":"Boisselier","year":"2010","journal-title":"Hum. Mutat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10014-011-0023-7","article-title":"Detection of IDH1 Mutation in Human Gliomas: Comparison of Immunohistochemistry and Sequencing","volume":"28","author":"Shingo","year":"2011","journal-title":"Brain Tumor Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH Mutation in Glioma: Molecular Mechanisms and Potential Therapeutic Targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An Integrated Genomic Analysis of Human Glioblastoma Multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acsmedchemlett.7b00421","article-title":"Discovery of Ag-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers","volume":"9","author":"Lemieux","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 Mutations Are Frequent Events in Central Chondrosarcoma and Central and Periosteal Chondromas but not in Other Mesenchymal Tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1158\/1078-0432.CCR-13-2649","article-title":"Circulating Oncometabolite 2-Hydroxyglutarate is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma","volume":"20","author":"Borger","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1634\/theoncologist.2013-0417","article-title":"Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated with Elevated Levels of Serum and Urine 2-Hydroxyglutarate","volume":"19","author":"Fathi","year":"2014","journal-title":"Oncologist"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Raimondi, V., Ciotti, G., Gottardi, M., and Ciccarese, F. (2022). 2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061359"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/neuonc\/nox183","article-title":"Glioma CpG Island Methylator Phenotype (G-Cimp): Biological and Clinical Implications","volume":"20","author":"Malta","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2016.02.007","article-title":"R132h Mutation in IDH1 Gene Reduces Proliferation, Cell Survival and Invasion of Human Glioma by Downregulating Wnt\/\u03b2-Catenin Signaling","volume":"73","author":"Cui","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13046-016-0362-7","article-title":"The Comparison of Clinical and Biological Characteristics between IDH1 and IDH2 Mutations in Gliomas","volume":"35","author":"Wang","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cbpa.2020.06.012","article-title":"Isocitrate Dehydrogenase Variants in Cancer\u2014Cellular Consequences and Therapeutic Opportunities","volume":"57","author":"Liu","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/modpathol.2012.210","article-title":"Expanding the Spectrum of IDH1 Mutations in Gliomas","volume":"26","author":"Gupta","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Haider, A.S., Ene, C.I., Palmisciano, P., Haider, M., Rao, G., Ballester, L.Y., and Fuller, G.N. (2023). Concurrent IDH1 and IDH2 Mutations in Glioblastoma: A Case Report. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1071792"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","article-title":"IDH1 and IDH2 Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives","volume":"18","author":"Yang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-Associated Metabolite 2-Hydroxyglutarate Accumulates in Acute Myelogenous Leukemia with Isocitrate Dehydrogenase 1 and 2 Mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_24","unstructured":"Jasiulionis, M.G. (2022). Chapter 11\u2014Oncometabolites, Epigenetic Marks, and DNA Repair. Epigenetics and DNA Damage, Academic Press."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","article-title":"Prolyl 4-Hydroxylases, the Key Enzymes of Collagen Biosynthesis","volume":"22","author":"Johanna","year":"2003","journal-title":"Matrix Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1158\/0008-5472.CAN-14-0680","article-title":"Hyperpolarized [1-13c] Glutamate: A Metabolic Imaging Biomarker of IDH1 Mutational Status in Glioma","volume":"74","author":"Chaumeil","year":"2014","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Philipp, K., Sahm, F., Radbruch, A., Wick, W., Heiland, S., von Deimling, A., Bendszus, M., and Wiestler, B. (2015). IDH Mutation Status Is Associated with a Distinct Hypoxia\/Angiogenesis Transcriptome Signature Which is Non-Invasively Predictable with Rcbv Imaging in Human Glioma. Sci. Rep., 5.","DOI":"10.1038\/srep16238"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chou, F.J., Liu, Y., Lang, F., and Yang, C. (2021). D-2-Hydroxyglutarate in Glioma Biology. Cells, 10.","DOI":"10.3390\/cells10092345"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 Mutation Is Sufficient to Establish the Glioma Hypermethylator Phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Letitia, S., and Fujimori, D.G. (2023). Recent Developments in Catalysis and Inhibition of the Jumonji Histone Demethylases. Curr. Opin. Struct. Biol., 83.","DOI":"10.1016\/j.sbi.2023.102707"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41392-022-01145-1","article-title":"Jmjd Family Proteins in Cancer and Inflammation","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-020-03380-2","article-title":"Histone Demethylase KDM4C Controls Tumorigenesis of Glioblastoma by Epigenetically Regulating p53 and c-Myc","volume":"12","author":"Lee","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-021-01041-1","article-title":"The Emerging Role of KDM5A in Human Cancer","volume":"14","author":"Yang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41568-020-00303-3","article-title":"2-Oxoglutarate-Dependent Dioxygenases in Cancer","volume":"20","author":"Losman","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103519","DOI":"10.1016\/j.drudis.2023.103519","article-title":"Development of JmjC-Domain-Containing Histone Demethylase (KDM2-7) Inhibitors for Cancer Therapy","volume":"28","author":"Lan","year":"2023","journal-title":"Drug Discov. Today"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1158\/2159-8290.CD-22-0825","article-title":"(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers","volume":"13","author":"Gunn","year":"2023","journal-title":"Cancer Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cancergen.2014.11.001","article-title":"The Role of the Histone Demethylase KDM4A in Cancer","volume":"208","author":"Lissania","year":"2015","journal-title":"Cancer Genet."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wang, Z., Cai, H., Zhao, E., and Cui, H. (2022). The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.790129"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ota, K., Tong, K.I., Goto, K., Tomida, S., Komuro, A., Wang, Z., Nishio, K., and Okada, H. (2017). The H3k27 Demethylase, Utx, Regulates Adipogenesis in a Differentiation Stage-Dependent Manner. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173713"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-Hydroxyglutarate is a Competitive Inhibitor of \u03b1-Ketoglutarate-Dependent Dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-94-007-4525-4_13","article-title":"The Role of DNA Methylation and Histone Modifications in Transcriptional Regulation in Humans","volume":"61","author":"Miller","year":"2013","journal-title":"Subcell Biochem."},{"key":"ref_42","first-page":"3081","article-title":"Cancer-Associated 2-Oxoglutarate Analogues Modify Histone Methylation by Inhibiting Histone Lysine Demethylases","volume":"430 Pt B","author":"Tuomas","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevOncog.2015012997","article-title":"Histone Deacetylases and Mechanisms of Regulation of Gene Expression","volume":"20","author":"Chen","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"ref_44","first-page":"827","article-title":"The Mecp1 Complex Represses Transcription through Preferential Binding, Remodeling, and Deacetylating Methylated Nucleosomes","volume":"15","author":"Feng","year":"2001","journal-title":"Genes Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-021-03829-0","article-title":"IDH1 Mutant Glioma Is Preferentially Sensitive to the HDAC Inhibitor Panobinostat","volume":"154","author":"Sears","year":"2021","journal-title":"J. Neurooncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Matthew, C.G., Albano, R., Carnwath, T., Elahi, L., Behrmann, C.A., Pemberton, M., Woo, D., O\u2019Brien, E., Van Cauwenbergh, B., and Perentesis, J. (2023). HDAC1 and HDAC6 Are Essential for Driving Growth in IDH1 Mutant Glioma. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-33889-3"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41392-023-01537-x","article-title":"Tet (Ten-Eleven Translocation) Family Proteins: Structure, Biological Functions and Applications","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Christian, G., Rodrigues, C.E., Homann, T., and Kleuser, B. (2022). The Role of Ten-Eleven Translocation Proteins in Inflammation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.861351"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ng.3522","article-title":"Active DNA Demethylation at Enhancers during the Vertebrate Phylotypic Period","volume":"48","author":"Smits","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/acs.jpcb.9b11511","article-title":"Oxidized Derivatives of 5-Methylcytosine Alter the Stability and Dehybridization Dynamics of Duplex DNA","volume":"124","author":"Sanstead","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cancergen.2015.02.009","article-title":"5-Hydroxymethylcytosine in Cancer: Significance in Diagnosis and Therapy","volume":"208","author":"Vasanthakumar","year":"2015","journal-title":"Cancer Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13177","DOI":"10.1038\/ncomms13177","article-title":"5-Hydroxymethylcytosine Localizes to Enhancer Elements and Is Associated with Survival in Glioblastoma Patients","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Masashi, N., Saito, K., Aihara, K., Nagae, G., Yamamoto, S., Tatsuno, K., Ueda, H., Fukuda, S., Umeda, T., and Tanaka, S. (2019). DNA Demethylation is Associated with Malignant Progression of Lower-Grade Gliomas. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-38510-0"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2011-02-339747","article-title":"Tet2 Mutation is an Unfavorable Prognostic Factor in Acute Myeloid Leukemia Patients with Intermediate-Risk Cytogenetics","volume":"118","author":"Chou","year":"2011","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.trecan.2020.12.011","article-title":"Roles and Regulations of Tet Enzymes in Solid Tumors","volume":"7","author":"Bray","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.21037\/tcr-20-3149","article-title":"Comprehensively Analyze the Expression and Prognostic Role for Ten-Eleven Translocations (TETs) in Acute Myeloid Leukemia","volume":"9","author":"Huang","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1074\/jbc.M115.688762","article-title":"Fumarate and Succinate Regulate Expression of Hypoxia-Inducible Genes via Tet Enzymes","volume":"291","author":"Laukka","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","article-title":"Hypoxia Induces Production of L-2-Hydroxyglutarate","volume":"22","author":"Intlekofer","year":"2015","journal-title":"Cell Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1021\/acs.jmedchem.3c01820","article-title":"Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate","volume":"67","author":"Roman","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.2019004158","article-title":"TET Family Dioxygenases and the TET Activator Vitamin C in Immune Responses and Cancer","volume":"136","author":"Yue","year":"2020","journal-title":"Blood"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/15592294.2019.1666652","article-title":"Vitamin C in Combination with Inhibition of Mutant IDH1 Synergistically Activates TET Enzymes and Epigenetically Modulates Gene Silencing in Colon Cancer Cells","volume":"15","author":"Christian","year":"2020","journal-title":"Epigenetics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"110220","DOI":"10.1016\/j.celrep.2021.110220","article-title":"2-Hydroxyglutarate Destabilizes Chromatin Regulatory Landscape and Lineage Fidelity to Promote Cellular Heterogeneity","volume":"38","author":"Kusi","year":"2022","journal-title":"Cell Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1101\/gad.198200.112","article-title":"D-2-Hydroxyglutarate Produced by Mutant IDH1 Perturbs Collagen Maturation and Basement Membrane Function","volume":"26","author":"Sasaki","year":"2012","journal-title":"Genes Dev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic Signatures of Cancer Cells and Stem Cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Frost, J., Frost, M., Batie, M., Jiang, H., and Rocha, S. (2021). Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia. Cancers, 13.","DOI":"10.3390\/cancers13020350"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"D\u2019Ignazio, L., Batie, M., and Rocha, S. (2017). Hypoxia and Inflammation in Cancer, Focus on HIF and Nf-\u03bab. Biomedicines, 5.","DOI":"10.20944\/preprints201703.0240.v1"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tibs.2007.06.005","article-title":"Gene Regulation under Low Oxygen: Holding Your Breath for Transcription","volume":"32","author":"Rocha","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-Enantiomer of 2-Hydroxyglutarate Linked to Egln Activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-Inducible Factors and the Response to Hypoxic Stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e1445454","DOI":"10.1080\/2162402X.2018.1445454","article-title":"D-2-Hydroxyglutarate Interferes with HIF-1\u03b1 Stability Skewing T-Cell Metabolism Towards Oxidative Phosphorylation and Impairing Th17 Polarization","volume":"7","author":"Renner","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular Ascorbate Enhances Hypoxia-Inducible Factor (HIF)-Hydroxylase Activity and Preferentially Suppresses the HIF-1 Transcriptional Response","volume":"69","author":"Kuiper","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Miles, S.L., Fischer, A.P., Joshi, S.J., and Niles, R.M. (2015). Ascorbic Acid and Ascorbate-2-Phosphate Decrease HIF Activity and Malignant Properties of Human Melanoma Cells. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1878-5"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The Oncometabolite 2-Hydroxyglutarate Inhibits Histone Lysine Demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate Links TCA Cycle Dysfunction to Oncogenesis by Inhibiting HIF-Alpha Prolyl Hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF Overexpression Correlates with Biallelic Loss of Fumarate Hydratase in Renal Cancer: Novel Role of Fumarate in Regulation of HIF Stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s12276-022-00897-8","article-title":"Biological Roles of the RNA M6a Modification and Its Implications in Cancer","volume":"54","author":"Hong","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"M6a Modification in Coding and Non-Coding RNAs: Roles and Therapeutic Implications in Cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s12264-022-00866-1","article-title":"Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma","volume":"38","author":"Tang","year":"2022","journal-title":"Neurosci. Bull."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/2767-9764.CRC-23-0271","article-title":"D-2-Hg Inhibits IDH1mut Glioma Growth via FTO Inhibition and Resultant M6a Hypermethylation","volume":"4","author":"Pianka","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omto.2021.06.017","article-title":"R-2HG Downregulates Er\u03b1 to Inhibit Cholangiocarcinoma Via the FTO\/M6a-Methylated Er\u03b1\/MIR16-5p\/YAP1 Signal Pathway","volume":"23","author":"Gao","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG Exhibits Anti-Tumor Activity by Targeting FTO\/M6a\/MYC\/CEBPA Signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-Hydroxyglutarate Attenuates Aerobic Glycolysis in Leukemia by Targeting the FTO\/M6A\/PFKP\/LDHB Axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.molcel.2016.09.034","article-title":"High-Resolution Mapping of RNA-Binding Regions in the Nuclear Proteome of Embryonic Stem Cells","volume":"64","author":"He","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aac5253","article-title":"RNA Biochemistry. Transcriptome-Wide Distribution and Function of RNA Hydroxymethylcytosine","volume":"351","author":"Delatte","year":"2016","journal-title":"Science"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature25434","article-title":"TET2 Promotes Pathogen Infection-Induced Myelopoiesis through MRNA Oxidation","volume":"554","author":"Shen","year":"2018","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Tran, P.M.H., Tran, L.K.H., Nechtman, J., dos Santos, B., Purohit, S., Bin Satter, K., Dun, B., Kolhe, R., Sharma, S., and Bollag, R. (2020). Comparative Analysis of Transcriptomic Profile, Histology, and IDH Mutation for Classification of Gliomas. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-77777-6"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1007\/s12035-016-0150-6","article-title":"Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses","volume":"54","author":"Cheng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Dusten, U., Zewde, M., Buss, A., Drumm, M.R., Tran, A.N., Scholtens, D.M., and Horbinski, C. (2019). Methylation and Transcription Patterns are Distinct in IDH Mutant Gliomas Compared to Other IDH Mutant Cancers. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-45346-1"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41388-021-02056-1","article-title":"Wild-Type Isocitrate Dehydrogenase under the Spotlight in Glioblastoma","volume":"41","author":"Alzial","year":"2022","journal-title":"Oncogene"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive Glutamine Metabolism by IDH1 Mediates Lipogenesis under Hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive Carboxylation Supports Growth in Tumour Cells with Defective Mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/cb500683c","article-title":"Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite D-2-Hydroxyglutarate","volume":"10","author":"Fan","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/acs.jproteome.8b00663","article-title":"Integrated Metabolomics and Lipidomics Analyses Reveal Metabolic Reprogramming in Human Glioma with IDH1 Mutation","volume":"18","author":"Zhou","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 Years of the Warburg Effect: A Cancer Metabolism Endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"49165","DOI":"10.18632\/oncotarget.17106","article-title":"In Silico Gene Expression Analysis Reveals Glycolysis and Acetate Anaplerosis in IDH1 Wild-Type Glioma and Lactate and Glutamate Anaplerosis in IDH1-Mutated Glioma","volume":"8","author":"Khurshed","year":"2017","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/neuonc\/not243","article-title":"Lactate Dehydrogenase a Silencing in IDH Mutant Gliomas","volume":"16","author":"Chesnelong","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nicl.2016.06.018","article-title":"Hyperpolarized (13)C Mr Imaging Detects No Lactate Production in Mutant IDH1 Gliomas: Implications for Diagnosis and Response Monitoring","volume":"12","author":"Chaumeil","year":"2016","journal-title":"Neuroimage Clin."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1096\/fj.201902352R","article-title":"Metabolic Changes Related to the IDH1 Mutation in Gliomas Preserve TCA-Cycle Activity: An Investigation at the Protein Level","volume":"34","author":"Dekker","year":"2020","journal-title":"FASEB J."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Arnold, P.K., and Finley, L.W.S. (2023). Regulation and Function of the Mammalian Tricarboxylic Acid Cycle. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2022.102838"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Biedermann, J., Preussler, M., Conde, M., Peitzsch, M., Richter, S., Wiedemuth, R., Abou-El-Ardat, K., Kr\u00fcger, A., Meinhardt, M., and Schackert, G. (2019). Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. Cancers, 11.","DOI":"10.3390\/cancers11122028"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.15252\/emmm.201707729","article-title":"Altered Metabolic Landscape in IDH-Mutant Gliomas Affects Phospholipid, Energy, and Oxidative Stress Pathways","volume":"9","author":"Fack","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Izquierdo-Garcia, J.L., Cai, L.M., Chaumeil, M.M., Eriksson, P., Robinson, A.E., Pieper, R.O., Phillips, J.J., and Ronen, S.M. (2014). Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108289"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.201800907RR","article-title":"Isocitrate Dehydrogenase 1-Mutated Human Gliomas Depend on Lactate and Glutamate to Alleviate Metabolic Stress","volume":"33","author":"Lenting","year":"2019","journal-title":"FASEB J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/acsomega.1c06121","article-title":"Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures","volume":"7","author":"Dekker","year":"2022","journal-title":"ACS Omega"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cell.2018.08.038","article-title":"Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma","volume":"175","author":"McBrayer","year":"2018","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nm.3217","article-title":"Bcat1 Promotes Cell Proliferation through Amino Acid Catabolism in Gliomas Carrying Wild-Type IDH1","volume":"19","author":"Tonjes","year":"2013","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc.2016.81","article-title":"Serine and One-Carbon Metabolism in Cancer","volume":"16","author":"Yang","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.celrep.2018.02.084","article-title":"Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis","volume":"22","author":"Hollinshead","year":"2018","journal-title":"Cell Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.celrep.2017.12.050","article-title":"Consumption of Nadph for 2-Hg Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress","volume":"22","author":"Gelman","year":"2018","journal-title":"Cell Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.celrep.2018.10.099","article-title":"Oncogenic R132 IDH1 Mutations Limit Nadph for de Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells","volume":"25","author":"Badur","year":"2018","journal-title":"Cell Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-14-0008","article-title":"IDH1 R132H Mutation Generates a Distinct Phospholipid Metabolite Profile in Glioma","volume":"74","author":"Esmaeili","year":"2014","journal-title":"Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Izquierdo-Garcia, J.L., Viswanath, P., Eriksson, P., Chaumeil, M.M., Pieper, R.O., Phillips, J.J., and Ronen, S.M. (2015). Metabolic Reprogramming in Mutant IDH1 Glioma Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118781"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20734","DOI":"10.1074\/jbc.R115.656462","article-title":"The Alkb Family of Fe(Ii)\/\u03b1-Ketoglutarate-Dependent Dioxygenases: Repairing Nucleic Acid Alkylation Damage and Beyond","volume":"290","author":"Fedeles","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1021\/acs.chemrestox.7b00009","article-title":"Oncometabolites D- and L-2-Hydroxyglutarate Inhibit the ALKB Family DNA Repair Enzymes under Physiological Conditions","volume":"30","author":"Chen","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1158\/1078-0432.CCR-18-3205","article-title":"Tissue 2-Hydroxyglutarate as a Biomarker for Isocitrate Dehydrogenase Mutations in Gliomas","volume":"25","author":"Sim","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.celrep.2015.11.029","article-title":"Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents","volume":"13","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4143\/crt.2020.506","article-title":"Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM\/CHK2 Pathway in Glioma","volume":"53","author":"Lin","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"10389","DOI":"10.1073\/pnas.190030497","article-title":"Ataxia Telangiectasia-Mutated Phosphorylates CHK2 in Vivo and in Vitro","volume":"97","author":"Matsuoka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ccell.2016.05.018","article-title":"Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2","volume":"30","author":"Inoue","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/1078-0432.CCR-22-1896","article-title":"Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance","volume":"29","author":"Carney","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1038\/s41467-021-26864-x","article-title":"ZMYND8 Mediated Liquid Condensates Spatiotemporally Decommission the Latent Super-Enhancers during Macrophage Polarization","volume":"12","author":"Jia","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.celrep.2016.09.037","article-title":"ZMYND8 Co-Localizes with Nurd on Target Genes and Regulates Poly(ADP-Ribose)-Dependent Recruitment of GATAD2A\/Nurd to Sites of DNA Damage","volume":"17","author":"Spruijt","year":"2016","journal-title":"Cell Rep."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.36401\/JIPO-20-20","article-title":"The Promise of Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in Gliomas","volume":"3","author":"Nazanin","year":"2020","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40170-018-0177-4","article-title":"Metabolic Characterization of Isocitrate Dehydrogenase (IDH) Mutant and IDH Wildtype Gliomaspheres Uncovers Cell Type-Specific Vulnerabilities","volume":"6","author":"Garrett","year":"2018","journal-title":"Cancer Metab."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Han, X., Zhou, H., Sun, W., Hou, L., Wang, Y., Wang, H., Lv, Z., and Xue, X. (2023). IDH1R132H Mutation Increases Radiotherapy Efficacy and a 4-Gene Radiotherapy-Related Signature of Who Grade 4 Gliomas. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-46335-1"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2015.08.007","article-title":"IDH1(R132H) Mutation Causes a Less Aggressive Phenotype and Radiosensitizes Human Malignant Glioma Cells Independent of the Oxygenation Status","volume":"116","author":"Kessler","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-013-0345-4","article-title":"IDH1 and IDH2 Mutations in Gliomas","volume":"13","author":"Cohen","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.18632\/oncotarget.588","article-title":"Frequent ATRX, CIC, FUBP1 and IDH1 Mutations Refine the Classification of Malignant Gliomas","volume":"3","author":"Jiao","year":"2012","journal-title":"Oncotarget"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"eaaq1427","DOI":"10.1126\/scitranslmed.aaq1427","article-title":"IDH1-R132H Acts as a Tumor Suppressor in Glioma via Epigenetic up-Regulation of the DNA Damage Response","volume":"11","author":"Mendez","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e24454","DOI":"10.1016\/j.heliyon.2024.e24454","article-title":"Oncometabolite 2-Hydroxyglutarate Regulates Anti-Tumor Immunity","volume":"10","author":"Cai","year":"2024","journal-title":"Heliyon"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3174\/ajnr.A6102","article-title":"Extent of Surgical Resection in Lower-Grade Gliomas: Differential Impact Based on Molecular Subtype","volume":"40","author":"Patel","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"12550","DOI":"10.1073\/pnas.1405839111","article-title":"Mri-Localized Biopsies Reveal Subtype-Specific Differences in Molecular and Cellular Composition at the Margins of Glioblastoma","volume":"111","author":"Gill","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor Heterogeneity in Human Glioblastoma Reflects Cancer Evolutionary Dynamics","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"101249","DOI":"10.1016\/j.xcrm.2023.101249","article-title":"Tumor Heterogeneity and Tumor-Microglia Interactions in Primary and Recurrent IDH1-Mutant Gliomas","volume":"4","author":"Narayanan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The Implications of IDH Mutations for Cancer Development and Therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40291-022-00612-3","article-title":"Glioma 2021 Who Classification: The Superiority of NGS over IHC in Routine Diagnostics","volume":"26","author":"Paulina","year":"2022","journal-title":"Mol. Diagn. Ther."},{"key":"ref_139","first-page":"vdad069","article-title":"The Prognostic Impact of Subclonal IDH1 Mutation in Grade 2-4 Astrocytomas","volume":"5","author":"Vij","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jmoldx.2020.04.213","article-title":"Next-Generation Sequencing in High-Sensitive Detection of Mutations in Tumors: Challenges, Advances, and Applications","volume":"22","author":"Singh","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Pei, X.M., Yeung, M.H.Y., Wong, A.N.N., Tsang, H.F., Yu, A.C.S., Yim, A.K.Y., and Wong, S.C.C. (2023). Targeted Sequencing Approach and Its Clinical Applications for the Molecular Diagnosis of Human Diseases. Cells, 12.","DOI":"10.3390\/cells12030493"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4","DOI":"10.20892\/j.issn.2095-3941.2018.0055","article-title":"Next-Generation Sequencing and Its Clinical Application","volume":"16","author":"Qin","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/neuonc\/nov289","article-title":"Targeted Next-Generation Sequencing Panel (GLIOSEQ) Provides Comprehensive Genetic Profiling of Central Nervous System Tumors","volume":"18","author":"Nikiforova","year":"2015","journal-title":"Neuro-Oncology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12367","article-title":"Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel","volume":"27","author":"Angela","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1111\/cas.14597","article-title":"A Tailored Next-Generation Sequencing Panel Identified Distinct Subtypes of Wildtype IDH and Tert Promoter Glioblastomas","volume":"111","author":"Nayuta","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Maria, G., Guarnaccia, L., La Cognata, V., Navone, S.E., Campanella, R., Ampollini, A., Locatelli, M., Miozzo, M., Marfia, G., and Cavallaro, S. (2022). A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life, 12.","DOI":"10.3390\/life12070956"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Elena, T., Massimino, M., Broggi, G., Romano, C., Minasi, S., Gianno, F., Antonelli, M., Motta, G., Certo, F., and Altieri, R. (2022). A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients with Diffuse Gliomas: Diagnostic and Therapeutic Applications. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.861078"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jmoldx.2021.06.004","article-title":"Next-Generation Sequencing Panel for 1p\/19q Codeletion and IDH1-IDH2 Mutational Analysis Uncovers Mistaken Overdiagnoses of 1p\/19q Codeletion by fish","volume":"23","author":"Acquaviva","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s40478-020-01000-w","article-title":"A Comprehensive DNA Panel Next Generation Sequencing Approach Supporting Diagnostics and Therapy Prediction in Neurooncology","volume":"8","author":"Lorenz","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.21873\/invivo.12881","article-title":"Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors","volume":"36","author":"Yaltirik","year":"2022","journal-title":"Vivo"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e13203","DOI":"10.1111\/bpa.13203","article-title":"Exploiting Nanopore Sequencing for Characterization and Grading of IDH-Mutant Gliomas","volume":"34","author":"Wongsurawat","year":"2024","journal-title":"Brain Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jmoldx.2022.12.001","article-title":"A Novel Approach to Detect IDH Point Mutations in Gliomas Using Nanopore Sequencing: Test Validation for the Clinical Laboratory","volume":"25","author":"Mimosa","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00401-022-02415-6","article-title":"Rapid-CNS2: Rapid Comprehensive Adaptive Nanopore-Sequencing of Cns Tumors, a Proof-of-Concept Study","volume":"143","author":"Patel","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11060-024-04563-z","article-title":"The Development of a Custom RNA-Sequencing Panel for the Identification of Predictive and Diagnostic Biomarkers in Glioma","volume":"167","author":"Shirai","year":"2024","journal-title":"J. Neuro-Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrg.2016.10","article-title":"Translating RNA Sequencing into Clinical Diagnostics: Opportunities and Challenges","volume":"17","author":"Byron","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-020-17186-5","article-title":"Single-Cell RNA-Seq Reveals That Glioblastoma Recapitulates a Normal Neurodevelopmental Hierarchy","volume":"11","author":"Couturier","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","article-title":"Single-Cell and Spatial Transcriptomics: Deciphering Brain Complexity in Health and Disease","volume":"19","author":"Piwecka","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","article-title":"Decoupling Genetics, Lineages, and Microenvironment in IDH-Mutant Gliomas by Single-Cell RNA-Seq","volume":"355","author":"Venteicher","year":"2017","journal-title":"Science"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1158\/1078-0432.CCR-17-3800","article-title":"Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid","volume":"24","author":"Mayor","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41416-021-01594-5","article-title":"Cell-Free DNA Technologies for the Analysis of Brain Cancer","volume":"126","author":"Mair","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal Fluid-Derived Circulating Tumour DNA Better Represents the Genomic Alterations of Brain Tumours Than Plasma","volume":"6","author":"Mayor","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40478-020-00963-0","article-title":"A Novel CAS9-Targeted Long-Read Assay for Simultaneous Detection of IDH1\/2 Mutations and Clinically Relevant Mgmt Methylation in Fresh Biopsies of Diffuse Glioma","volume":"8","author":"Wongsurawat","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Feng, Z., Kong, D., Jin, W., He, K., Zhao, J., Liu, B., Xu, H., Yu, X., and Feng, S. (2023). Rapid Detection of Isocitrate Dehydrogenase 1 Mutation Status in Glioma Based on Crispr-Cas12a. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-32957-y"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41698-024-00632-8","article-title":"Combination of MRI-Based Prediction and Crispr\/Cas12a-Based Detection for IDH Genotyping in Glioma","volume":"8","author":"Yu","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.scib.2020.04.041","article-title":"Rapid and Sensitive Detection of COVID-19 Using CRISPR\/CAS12A-Based Detection with Naked Eye Readout, Crispr\/Cas12a-Ner","volume":"65","author":"Wang","year":"2020","journal-title":"Sci Bull"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Tsou, J.H., Leng, Q., and Jiang, F. (2020). A Crispr Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations. Diagnostics, 10.","DOI":"10.3390\/diagnostics10020114"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1074\/jbc.RA120.012933","article-title":"CRISPR-CAS12A Has Widespread Off-Target and DSDNA-Nicking Effects","volume":"295","author":"Murugan","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymthe.2021.10.010","article-title":"CAS12A Variants Designed for Lower Genome-Wide Off-Target Effect through Stringent Pam Recognition","volume":"30","author":"Zhou","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/gcc.22062","article-title":"Molecular Subtypes of Glioma Identified by Genome-Wide Methylation Profiling","volume":"52","author":"Kloosterhof","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00401-018-1879-y","article-title":"Practical Implementation of DNA Methylation and Copy-Number-Based CNS Tumor Diagnostics: The Heidelberg Experience","volume":"136","author":"Capper","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng.3457","article-title":"Integrated Genomic Characterization of IDH1-Mutant Glioma Malignant Progression","volume":"48","author":"Bai","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Schenkel, L.C., Mathew, J., Hirte, H., Provias, J., Par\u00e9, G., Chong, M., Grafodatskaya, D., and McCready, E. (2022). Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1\/IDH2 Mutant and Wild-Type Tumors. Genes, 13.","DOI":"10.3390\/genes13112075"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00401-017-1743-5","article-title":"Same-Day Genomic and Epigenomic Diagnosis of Brain Tumors Using Real-Time Nanopore Sequencing","volume":"134","author":"Euskirchen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Willscher, E., Hopp, L., Kreuz, M., Schmidt, M., Hakobyan, S., Arakelyan, A., Hentschel, B., Jones, D.T.W., Pfister, S.M., and Loeffler, M. (2021). High-Resolution Cartography of the Transcriptome and Methylome Landscapes of Diffuse Gliomas. Cancers, 13.","DOI":"10.3390\/cancers13133198"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wenger, A., and Car\u00e9n, H. (2022). Methylation Profiling in Diffuse Gliomas: Diagnostic Value and Considerations. Cancers, 14.","DOI":"10.3390\/cancers14225679"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"vdab149","DOI":"10.1093\/noajnl\/vdab149","article-title":"Intraoperative DNA Methylation Classification of Brain Tumors Impacts Neurosurgical Strategy","volume":"3","author":"Djirackor","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Zhang, J., Xie, S., Xu, J., Liu, H., and Wan, S. (2021). Cancer Biomarkers Discovery of Methylation Modification with Direct High-Throughput Nanopore Sequencing. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.672804"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/neuonc\/not159","article-title":"IDH1 Mutant Malignant Astrocytomas Are More Amenable to Surgical Resection and Have a Survival Benefit Associated with Maximal Surgical Resection","volume":"16","author":"Beiko","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nec.2020.09.006","article-title":"Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era","volume":"32","author":"Cahill","year":"2021","journal-title":"Neurosurg. Clin. N. Am."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3171\/2022.1.JNS212514","article-title":"The Impact of Resection in IDH-Mutant Who Grade 2 Gliomas: A Retrospective Population-Based Parallel Cohort Study","volume":"137","author":"Jakola","year":"2022","journal-title":"J. Neurosurg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-022-01335-6","article-title":"Droplet Digital PCR-Based Analyses for Robust, Rapid, and Sensitive Molecular Diagnostics of Gliomas","volume":"10","author":"Wolter","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"39651","DOI":"10.18632\/oncotarget.5630","article-title":"IDH1 Mutation Detection by Droplet Digital PCR in Glioma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1750-3639.2012.00579.x","article-title":"IDH Mutation Detection in Formalin-Fixed Paraffin-Embedded Gliomas Using Multiplex PCR and Single-Base Extension","volume":"22","author":"Perizzolo","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1038\/mtna.2013.28","article-title":"Beaming and Droplet Digital PCR Analysis of Mutant IDH1 MRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles","volume":"2","author":"Chen","year":"2013","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"101531","DOI":"10.1016\/j.mcp.2020.101531","article-title":"Comparing the Performance of Conventional PCR, RTQ-PCR, and Droplet Digital PCR Assays in Detection of Shigella","volume":"51","author":"Yang","year":"2020","journal-title":"Mol. Cell. Probes"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1158\/1078-0432.CCR-22-2903","article-title":"Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation","volume":"29","author":"Orzan","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Crucitta, S., Pasqualetti, F., Gonnelli, A., Ruglioni, M., Luculli, G.I., Cantarella, M., Ortenzi, V., Scatena, C., Paiar, F., and Naccarato, A.G. (2024). IDH1 Mutation Is Detectable in Plasma Cell-Free DNA and Is Associated with Survival Outcome in Glioma Patients. BMC Cancer, 24.","DOI":"10.1186\/s12885-023-11726-0"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"vdae027","DOI":"10.1093\/noajnl\/vdae027","article-title":"Plasma Ctdna Liquid Biopsy of IDH1, TERTP, and EGFRVIII Mutations in Glioma","volume":"6","author":"Jones","year":"2024","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"961","DOI":"10.31557\/APJCP.2023.24.3.961","article-title":"Detection of IDH1 Mutation in CFDNA and Tissue of Adult Diffuse Glioma with ALLELE-Specific QPCR","volume":"24","author":"Husain","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13000-024-01492-3","article-title":"Evaluation of the Rapid Idylla IDH1-2 Mutation Assay in FFPE Glioma Samples","volume":"19","author":"Solomon","year":"2024","journal-title":"Diagn. Pathol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Choate, K.A., Raack, E.J., Line, V.F., Jennings, M.J., Belton, R.J., Jr Winn, R.J., and Mann, P.B. (2023). Rapid Extraction-Free Detection of the R132h Isocitrate Dehydrogenase Mutation in Glioma Using Colorimetric Peptide Nucleic Acid-Loop Mediated Isothermal Amplification (CPNA-Lamp). PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0291666"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Choate, K.A., Raack, E.J., Mann, P.B., Jones, E.A., Winn, R.J., and Jennings, M.J. (2024). Rapid IDH1-R132 Genotyping Panel Utilizing Locked Nucleic Acid Loop-Mediated Isothermal Amplification (LNA-Lamp). Biol. Methods Protoc., 9.","DOI":"10.1093\/biomethods\/bpae012"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/his.13756","article-title":"Frequent False-Negative Immunohistochemical Staining with IDH1 (R132h)-Specific H09 Antibody on Frozen Section Control Slides: A Potential Pitfall in Glioma Diagnosis","volume":"74","author":"Yoshida","year":"2019","journal-title":"Histopathology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","article-title":"Monoclonal Antibody Specific for IDH1 R132h Mutation","volume":"118","author":"Capper","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2009.10.001","article-title":"A Monoclonal Antibody Imab-1 Specifically Recognizes IDH1R132H, the Most Common Glioma-Derived Mutation","volume":"390","author":"Kato","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10014-014-0202-4","article-title":"Specific Monoclonal Antibodies against IDH1\/2 Mutations as Diagnostic Tools for Gliomas","volume":"32","author":"Kato","year":"2015","journal-title":"Brain Tumor Pathol."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Copaciu, R., Rashidian, J., Lloyd, J., Yahyabeik, A., McClure, J., Cummings, K., and Su, Q. (2023). Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas. Antibodies, 12.","DOI":"10.3390\/antib12010014"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Rashidian, J., Copaciu, R., Su, Q., Merritt, B., Johnson, C., Yahyabeik, A., French, E., and Cummings, K. (2017). Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody. Antibodies, 6.","DOI":"10.3390\/antib6040022"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2217\/cns-2017-0019","article-title":"Isocitrate Dehydrogenase 1 Mutation Subtypes at Site 132 and Their Translational Potential in Glioma","volume":"7","author":"Lu","year":"2018","journal-title":"CNS Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/neuonc\/not015","article-title":"Comparative Study of IDH1 Mutations in Gliomas by Immunohistochemistry and DNA Sequencing","volume":"15","author":"Agarwal","year":"2013","journal-title":"Neuro Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2374289520914021","DOI":"10.1177\/2374289520914021","article-title":"Educational Case: Histologic and Molecular Features of Diffuse Gliomas","volume":"7","author":"Zhang","year":"2020","journal-title":"Acad. Pathol."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Nakagaki, R., Debsarkar, S.S., Kawanaka, H., Aronow, B.J., and Prasath, V.B.S. (2024). Deep Learning-Based IDH1 Gene Mutation Prediction Using Histopathological Imaging and Clinical Data. Comput. Biol. Med., 179.","DOI":"10.1016\/j.compbiomed.2024.108902"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Liu, S., Shah, Z., Sav, A., Russo, C., Berkovsky, S., Qian, Y., Coiera, E., and Di Ieva, A. (2020). Isocitrate Dehydrogenase (IDH) Status Prediction in Histopathology Images of Gliomas Using Deep Learning. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64588-y"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Liechty, B., Xu, Z., Zhang, Z., Slocum, C., Bahadir, C.D., Sabuncu, M.R., and Pisapia, D.J. (2022). Machine Learning Can Aid in Prediction of IDH Mutation from H&E-Stained Histology Slides in Infiltrating Gliomas. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-26170-6"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"vdac111","DOI":"10.1093\/noajnl\/vdac111","article-title":"Prognostic Risk Stratification of Gliomas Using Deep Learning in Digital Pathology Images","volume":"4","author":"Chunduru","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/cmb.2019.0410","article-title":"A Multiple-Instance Learning-Based Convolutional Neural Network Model to Detect the IDH1 Mutation in the Histopathology Images of Glioma Tissues","volume":"27","author":"Cui","year":"2020","journal-title":"J. Comput. Biol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10014-014-0197-x","article-title":"IDH1\/2 Mutation Detection in Gliomas","volume":"32","author":"Arita","year":"2015","journal-title":"Brain Tumor Pathol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41421-020-00227-0","article-title":"Structure, Substrate Specificity, and Catalytic Mechanism of Human D-2-HGDH and Insights into Pathogenicity of Disease-Associated Mutations","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Discov."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"de Goede, K.E., Harber, K.J., Gorki, F.S., Verberk, S.G.S., Groh, L.A., Keuning, E.D., Struys, E.A., van Weeghel, M., Haschemi, A., and de Winther, M.P.J. (2022). D-2-Hydroxyglutarate Is an Anti-Inflammatory Immunometabolite That Accumulates in Macrophages after TLR4 Activation. Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1868.","DOI":"10.1016\/j.bbadis.2022.166427"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/BJ20031933","article-title":"Identification of a Dehydrogenase Acting on D-2-Hydroxyglutarate","volume":"381","author":"Achouri","year":"2004","journal-title":"Biochem. J."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-006-0317-9","article-title":"D-2-Hydroxyglutaric Aciduria: Unravelling the Biochemical Pathway and the Genetic Defect","volume":"29","author":"Struys","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/jnen\/nlac036","article-title":"Minimally Invasive Detection of IDH1 Mutation with Cell-Free Circulating Tumor DNA and D-2-Hydroxyglutarate, D\/L-2-Hydroxyglutarate Ratio in Gliomas","volume":"81","author":"Tuna","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1158\/1078-0432.CCR-15-2965","article-title":"Selective Detection of the D-Enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase","volume":"22","author":"Kalinina","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-022-04060-1","article-title":"IDH1 P.R132H CTDNA and D-2-Hydroxyglutarate as CSF Biomarkers in Patients with IDH-Mutant Gliomas","volume":"159","author":"Fujita","year":"2022","journal-title":"J. Neurooncol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/1535-7163.MCT-23-0460","article-title":"Circulating Oncometabolite 2-Hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1\/2) Mutant Cholangiocarcinoma","volume":"23","author":"Lee","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejca.2017.11.024","article-title":"Circulating Oncometabolite D-2-Hydroxyglutarate Enantiomer Is a Surrogate Marker of Isocitrate Dehydrogenase\u2013Mutated Intrahepatic Cholangiocarcinomas","volume":"90","author":"Delahousse","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Wood, P.L. (2021). Enantioseparation and Detection of (R)-2-Hydroxyglutarate and (S)-2-Hydroxyglutarate by Chiral Gas Chromatography\u2013Triple Quadrupole Mass Spectrometry. Metabolomics, Springer.","DOI":"10.1007\/978-1-0716-0864-7"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Voelxen, N.F., Walenta, S., Proescholdt, M., Dettmer, K., Pusch, S., and Mueller-Klieser, W. (2016). Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique. Front. Oncol., 6.","DOI":"10.3389\/fonc.2016.00046"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchromb.2018.02.038","article-title":"Validation of a Routine Gas Chromatography Mass Spectrometry Method for 2-Hydroxyglutarate Quantification in Human Serum as a Screening Tool for Detection of IDH Mutations","volume":"1083","author":"Massana","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-Hydroxyglutarate Detection by Magnetic Resonance Spectroscopy in IDH-Mutated Patients with Gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00401-012-1060-y","article-title":"Enzymatic Assay for Quantitative Analysis of (D)-2-Hydroxyglutarate","volume":"124","author":"Balss","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"133681","DOI":"10.1016\/j.snb.2023.133681","article-title":"A F\u00f6rster Resonance Energy Transfer-Based D-2-Hydroxyglutarate Biosensor","volume":"385","author":"Xiao","year":"2023","journal-title":"Sens. Actuators B Chem."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Choate, K.A., Konickson, W.W.L., Jennings, M.J., Mann, P.B., Winn, R.J., Kamson, D.O., and Pratt, E.P.S. (2024). A Genetically Encoded Fluorescent Sensor Enables Sensitive and Specific Detection of IDH Mutant Associated Oncometabolite D-2-Hydroxyglutarate. bioRxiv.","DOI":"10.1101\/2024.09.25.615072"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00280-020-04064-6","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Ivosidenib in Patients with Advanced Hematologic Malignancies with an IDH1 Mutation","volume":"85","author":"Fan","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10637-019-00771-x","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Ivosidenib, an Oral, Targeted Inhibitor of Mutant IDH1, in Patients with Advanced Solid Tumors","volume":"38","author":"Fan","year":"2020","journal-title":"Investig. New Drugs"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2051-5960-2-19","article-title":"D-2-Hydroxyglutarate Producing Neo-Enzymatic Activity Inversely Correlates with Frequency of the Type of Isocitrate Dehydrogenase 1 Mutations Found in Glioma","volume":"2","author":"Pusch","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3174\/ajnr.A4407","article-title":"Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation","volume":"36","author":"Wang","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3174\/ajnr.A2950","article-title":"Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, Mgmt Promoter Methylation, and Survival in Glioblastoma","volume":"33","author":"Carrillo","year":"2012","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3174\/ajnr.A5171","article-title":"Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade Ii and Iii Astrocytomas Using Dwi and Dsc-Pwi Combined with Conventional MR Imaging","volume":"38","author":"Xing","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.3390\/curroncol29100542","article-title":"Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis","volume":"29","author":"Li","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00002142-199612000-00005","article-title":"Fluid-Attenuated Inversion Recovery (Flair): Clinical Prospectus of Current and Future Applications","volume":"8","author":"Kates","year":"1996","journal-title":"Top. Magn. Reson. Imaging"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1158\/1078-0432.CCR-17-0560","article-title":"T2-Flair Mismatch, an Imaging Biomarker for IDH and 1p\/19q Status in Lower-Grade Gliomas: A TCGA\/TCIA Project","volume":"23","author":"Patel","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"20210825","DOI":"10.1259\/bjr.20210825","article-title":"T2-Flair Mismatch Sign: A Roadmap of Pearls and Pitfalls","volume":"95","author":"Pinto","year":"2022","journal-title":"Br. J. Radiol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/neuonc\/noaa041","article-title":"\u201cReal World\u201d Use of a Highly Reliable Imaging Sign: \u201cT2-Flair Mismatch\u201d for Identification of IDH Mutant Astrocytomas","volume":"22","author":"Jain","year":"2020","journal-title":"Neuro Oncol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/ajns.AJNS_191_16","article-title":"Role of Diffusion and Perfusion Magnetic Resonance Imaging in Predicting the Histopathological Grade of Gliomas\u2014A Prospective Study","volume":"14","author":"Shoaib","year":"2019","journal-title":"Asian J. Neurosurg."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43055-019-0127-3","article-title":"Perfusion and Permeability Mri in Glioma Grading","volume":"51","author":"Aydin","year":"2020","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"del Mar, \u00c1.-T.M., Fuster-Garc\u00eda, E., Juan-Albarrac\u00edn, J., Reyn\u00e9s, G., Aparici-Robles, F., Ferrer-Lozano, J., and Garc\u00eda-G\u00f3mez, J.M. (2022). Local Detection of Microvessels in IDH-Wildtype Glioblastoma Using Relative Cerebral Blood Volume: An Imaging Marker Useful for Astrocytoma Grade 4 Classification. BMC Cancer, 22.","DOI":"10.1186\/s12885-021-09117-4"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Feraco, P., Bacci, A., Ferrazza, P., van den Hauwe, L., Pertile, R., Girlando, S., Barbareschi, M., Gagliardo, C., Morganti, A.G., and Petralia, B. (2020). Magnetic Resonance Imaging Derived Biomarkers of IDH Mutation Status and Overall Survival in Grade III Astrocytomas. Diagnostics, 10.","DOI":"10.3390\/diagnostics10040247"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3174\/ajnr.A3803","article-title":"Can Diffusion Tensor Imaging Noninvasively Detect IDH1 Gene Mutations in Astrogliomas? A Retrospective Study of 112 Cases","volume":"35","author":"Tan","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e30183","DOI":"10.1097\/MD.0000000000030183","article-title":"Perfusion and Diffusion-Weighted Imaging Parameters: Comparison between Pre- and Postbiopsy MRI for High-Grade Glioma","volume":"101","author":"Kurokawa","year":"2022","journal-title":"Medicine"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Gihr, G., Horvath-Rizea, D., Kohlhof-Meinecke, P., Ganslandt, O., Henkes, H., H\u00e4rtig, W., Donitza, A., Skalej, M., and Schob, S. (2022). Diffusion Weighted Imaging in Gliomas: A Histogram-Based Approach for Tumor Characterization. Cancers, 14.","DOI":"10.3390\/cancers14143393"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"vdac124","DOI":"10.1093\/noajnl\/vdac124","article-title":"Early Volumetric, Perfusion, and Diffusion MRI Changes after Mutant Isocitrate Dehydrogenase (IDH) Inhibitor Treatment in IDH1-Mutant Gliomas","volume":"4","author":"Cho","year":"2022","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Stadlbauer, A., Nikolic, K., Oberndorfer, S., Marhold, F., Kinfe, T.M., Meyer-B\u00e4se, A., Bistrian, D.A., Schnell, O., and Doerfler, A. (2024). Machine Learning-Based Prediction of Glioma IDH Gene Mutation Status Using Physio-Metabolic MRI of Oxygen Metabolism and Neovascularization (a Bicenter Study). Cancers, 16.","DOI":"10.3390\/cancers16061102"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Yuan, J., Siakallis, L., Li, H.B., Brandner, S., Zhang, J., Li, C., Mancini, L., and Bisdas, S. (2024). Structural- and DTI-MRI Enable Automated Prediction of IDH Mutation Status in CNS Who Grade 2\u20134 Glioma Patients: A Deep Radiomics Approach. BMC Med. Imaging, 24.","DOI":"10.1186\/s12880-024-01274-9"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.21037\/qims-23-807","article-title":"A Fusion Model Integrating Magnetic Resonance Imaging Radiomics and Deep Learning Features for Predicting Alpha-Thalassemia X-Linked Intellectual Disability Mutation Status in Isocitrate Dehydrogenase-Mutant High-Grade Astrocytoma: A Multicenter Study","volume":"14","author":"Liu","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1016\/j.crad.2024.01.021","article-title":"T2-Flair Mismatch Sign and Machine Learning-Based Multiparametric MRI Radiomics in Predicting IDH Mutant 1p\/19q Non-Co-Deleted Diffuse Lower-Grade Gliomas","volume":"79","author":"Tang","year":"2024","journal-title":"Clin. Radiol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10278-023-00918-6","article-title":"Development of End-to-End Ai\u2013Based MRI Image Analysis System for Predicting IDH Mutation Status of Patients with Gliomas: Multicentric Validation","volume":"37","author":"Santinha","year":"2024","journal-title":"J. Imaging Inform. Med."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Pasquini, L., Napolitano, A., Tagliente, E., Dellepiane, F., Lucignani, M., Vidiri, A., Ranazzi, G., Stoppacciaro, A., Moltoni, G., and Nicolai, M. (2021). Deep Learning Can Differentiate IDH-Mutant from IDH-Wild Gbm. J. Pers. Med., 11.","DOI":"10.3390\/jpm11040290"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Carosi, F., Broseghini, E., Fabbri, L., Corradi, G., Gili, R., Forte, V., Roncarati, R., Filippini, D.M., and Ferracin, M. (2024). Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives. Cancers, 16.","DOI":"10.3390\/cancers16152752"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3171\/2022.12.JNS221954","article-title":"2-Hydroxyglutarate Magnetic Resonance Spectroscopy in Adult Brainstem Glioma","volume":"139","author":"Iwahashi","year":"2023","journal-title":"J. Neurosurg."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/neuonc\/noy113","article-title":"2-Hydroxyglutarate MR Spectroscopy for Prediction of Isocitrate Dehydrogenase Mutant Glioma: A Systemic Review and Meta-Analysis Using Individual Patient Data","volume":"20","author":"Suh","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00234-021-02702-1","article-title":"The Role of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy for the Determination of Isocitrate Dehydrogenase Status in Lower Grade Gliomas Versus Glioblastoma: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy","volume":"63","author":"Bhandari","year":"2021","journal-title":"Neuroradiology"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/neuonc\/nox214","article-title":"Highly Specific Determination of IDH Status Using Edited in Vivo Magnetic Resonance Spectroscopy","volume":"20","author":"Branzoli","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noy022","article-title":"Diagnostic Accuracy of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy in Newly Diagnosed Brain Mass and Suspected Recurrent Gliomas","volume":"20","author":"Zhou","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3171\/2016.10.JNS161793","article-title":"Noninvasive Assessment of Isocitrate Dehydrogenase Mutation Status in Cerebral Gliomas by Magnetic Resonance Spectroscopy in a Clinical Setting","volume":"128","author":"Tietze","year":"2018","journal-title":"J. Neurosurg."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1172\/JCI67229","article-title":"Detection of Oncogenic IDH1 Mutations Using Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate","volume":"123","author":"Andronesi","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/s41467-018-03905-6","article-title":"Pharmacodynamics of Mutant-IDH1 Inhibitors in Glioma Patients Probed by in Vivo 3d MRS Imaging of 2-Hydroxyglutarate","volume":"9","author":"Andronesi","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Liang, J., Lv, X., Lu, C., Ye, X., Chen, X., Fu, J., Luo, C., and Zhao, Y. (2020). Prognostic Factors of Patients with Gliomas\u2014An Analysis on 335 Patients with Glioblastoma and Other Forms of Gliomas. BMC Cancer, 20.","DOI":"10.1186\/s12885-019-6511-6"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"Cbtrus Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-018-1849-4","article-title":"Novel, Improved Grading System(S) for IDH-Mutant Astrocytic Gliomas","volume":"136","author":"Shirahata","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 Mutations in Gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_262","first-page":"209","article-title":"Association of Chromosome 7, Chromosome 10 and EGFR Gene Amplification in Glioblastoma Multiforme","volume":"24","author":"Pellin","year":"2005","journal-title":"Clin. Neuropathol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Jenkins. Glioma Groups Based on 1p\/19q, IDH, and TERT. Promoter Mutations in Tumors","volume":"372","author":"Lachance","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT Promoter Mutations Occur Frequently in Gliomas and a Subset of Tumors Derived from Cells with Low Rates of Self-Renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/nov010","article-title":"Prognostic Quality of Activating TERT Promoter Mutations in Glioblastoma: Interaction with the Rs2853669 Polymorphism and Patient Age at Diagnosis","volume":"17","author":"Ghanim","year":"2015","journal-title":"Neuro-Oncology"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40478-016-0331-6","article-title":"ATRX Immunostaining Predicts IDH and H3f3a Status in Gliomas","volume":"4","author":"Ebrahimi","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s40478-014-0158-y","article-title":"Accumulation of 2-Hydroxyglutarate in Gliomas Correlates with Survival: A Study by 3.0-Tesla Magnetic Resonance Spectroscopy","volume":"2","author":"Natsumeda","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The Somatic Genomic Landscape of Glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/neuonc\/nox132","article-title":"Prognostic Relevance of Genetic Alterations in Diffuse Lower-Grade Gliomas","volume":"20","author":"Aoki","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bpa.12801","article-title":"IDH Mutant Lower Grade (Who Grades Ii\/Iii) Astrocytomas Can Be Stratified for Risk by CDKN2A, CDK4 and PDGFRA Copy Number Alterations","volume":"30","author":"Yang","year":"2020","journal-title":"Brain Pathol."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.1239947","article-title":"Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma","volume":"343","author":"Johnson","year":"2014","journal-title":"Science"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng.3273","article-title":"Mutational Landscape and Clonal Architecture in Grade II and III Gliomas","volume":"47","author":"Suzuki","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/annonc\/mdv127","article-title":"Glioblastoma Adaptation Traced through Decline of an IDH1 Clonal Driver and Macro-Evolution of a Double-Minute Chromosome","volume":"26","author":"Favero","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00401-017-1780-0","article-title":"Diffuse Midline Gliomas with Subclonal H3F3A K27M Mutation and Mosaic H3.3 K27M Mutant Protein Expression","volume":"134","author":"Lopez","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/nan.12671","article-title":"IDH Clonal Heterogeneity Segregates a Subgroup of Non-1p\/19q Codeleted Gliomas with Unfavourable Clinical Outcome","volume":"47","author":"Luo","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse Glioma Heterogeneity and Its Therapeutic Implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5582\/irdr.2022.01019","article-title":"Diffuse Astrocytoma with Mosaic IDH1-R132H-Mutant Immuno-Phenotype and Low Subclonal Allele Frequency","volume":"11","author":"Morgan","year":"2022","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Bai, M., Wang, X., Zhang, H., Wang, J., Lyaysan, G., Xu, S., Tian, K., Wang, T., Li, J., and Wang, N. (2022). Dissecting and Analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma. Biomed. Res. Int., 2022.","DOI":"10.1155\/2022\/4919111"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/cjn.2023.253","article-title":"Methylation Profiling Identifies Stability of Isocitrate Dehydrogenase Mutation over Time","volume":"51","author":"Voisin","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11060-020-03609-2","article-title":"The Ability to Return to Work: A Patient-Centered Outcome Parameter Following Glioma Surgery","volume":"149","author":"Senft","year":"2020","journal-title":"J. Neurooncol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"jrm00198","DOI":"10.2340\/16501977-2837","article-title":"Long-Term Employment Status and the Association with Fatigue in Patients with Grade II Glioma","volume":"53","author":"Ernens","year":"2021","journal-title":"J. Rehabil. Med."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.clml.2016.04.006","article-title":"Evidence for Clinical Differentiation and Differentiation Syndrome in Patients with Acute Myeloid Leukemia and IDH1 Mutations Treated with the Targeted Mutant IDH1 Inhibitor, Ag-120","volume":"16","author":"Birendra","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_285","first-page":"373","article-title":"Targeting Isocitrate Dehydrogenase (IDH) in Cancer","volume":"21","author":"Fujii","year":"2016","journal-title":"Discov. Med."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1021\/acs.jmedchem.3c02482","article-title":"Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and Nampt for the Treatment of Glioma with IDH1mutation","volume":"67","author":"Wen","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_287","first-page":"296","article-title":"Panobinostat (Farydak): A Novel Option for the Treatment of Relapsed or Relapsed and Refractory Multiple Myeloma","volume":"41","author":"Moore","year":"2016","journal-title":"P&T"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.seminoncol.2023.03.006","article-title":"Outcomes with Panobinostat in Heavily Pretreated Multiple Myeloma Patients","volume":"50","author":"Pan","year":"2023","journal-title":"Semin. Oncol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bmcl.2018.03.083","article-title":"Structure-Based Design and Discovery of Potent and Selective KDM5 Inhibitors","volume":"28","author":"Nie","year":"2018","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40478-023-01669-9","article-title":"Genomic Characterization of IDH-Mutant Astrocytoma Progression to Grade 4 in the Treatment Setting","volume":"11","author":"Rautajoki","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-023-02662-1","article-title":"Improved Prognostic Stratification of Patients with Isocitrate Dehydrogenase-Mutant Astrocytoma","volume":"147","author":"Weller","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_292","first-page":"vdad053","article-title":"Isocitrate Dehydrogenase Mutations in Gliomas: A Review of Current Understanding and Trials","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Kayabolen, A., Yilmaz, E., and Bagci-Onder, T. (2021). IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070799"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/11\/885\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:24:31Z","timestamp":1760113471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/11\/885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":293,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["biology13110885"],"URL":"https:\/\/doi.org\/10.3390\/biology13110885","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}